Agomab vs Upstream Bio
Agomab
Unlocking Disease Modification in Fibro-Inflammation
78 employees · est. 2017 · Ghent, Belgium
Upstream Bio
Developing treatments for inflammatory diseases
78 employees · est. 2021 · Waltham, United States
Agomab is the older company (2017 vs 2021).
Side-by-Side Comparison
| Metric | Agomab | Upstream Bio |
|---|---|---|
| Founded | ||
| Founded | 2017 older | 2021 |
| Headquarters | ||
| Headquarters | Ghent, Belgium | Waltham, United States |
| Employees | ||
| Employees | 78 | 78 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series D | IPO |
| Total Funding | ||
| Total Funding | $310.40M | $693.00M |
| Funding Rounds | ||
| Funding Rounds | 5 | 4 |
| Services | ||
| Services | Development of novel disease-modifying therapies, Clinical trials for fibrosis and inflammatory diseases, Research in growth factor biology | Development of verekitug for targeting TSLP in inflammatory diseases, Conducting clinical trials for respiratory disease treatments, Research and innovation in chronic inflammatory diseases |
| Target Customers | ||
| Target Customers | Patients with fibrotic diseases, Healthcare professionals in immunology and inflammatory diseases, Investors interested in biopharmaceutical innovations | Patients with chronic respiratory diseases, Healthcare professionals specializing in respiratory health, Researchers and clinicians in the field of inflammatory diseases |
| Taxonomy | ||
| Taxonomy | Drug DevelopmentGrowth Factor BiologyFibrosis TreatmentTissue RepairOrgan Function RestorationClinical Pipeline +8 | Inflammatory DiseasesMonoclonal AntibodyClinical-stage TherapyVereKitugImmunotherapyTSLP Receptor Inhibition +5 |
| Website | ||
| Website | agomab.com | upstreambio.com |
About Agomab
Agomab is emerging as a significant player in the Biotechnology sector, established in 2017 and headquartered in Belgium. The company leverages its deep expertise in growth factor biology to innovate treatments aimed at resolving fibrosis, repairing tissue structures, and restoring organ functionali...
About Upstream Bio
Upstream Bio, founded in 2021, is a promising player in the Biotechnology sector with a focus on Health Care and Pharmaceuticals, headquartered in the United States. The company's slogan, "Developing treatments for inflammatory diseases," underscores its mission in the health and wellness arena. Ce...
Also comparing in this category
Comparing more than these two?
Get Agomab, Upstream Bio and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Agomab compare?
A PDF of Agomab and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Agomab with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Agomab on 12 Apr 2026, and Upstream Bio on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
